Abstract
Lectins are proteins / glycoproteins of non-immunological origin found ubiquitously in all organisms. Research investigations show that many types of diseased tissues often display glycans that vary from their normal counterparts. Therefore, lectins that can interact with these transformed glycans may be used for early diagnosis and treatment of diseases. Specificity of lectins towards glycans has greatly attracted nanobiotechnology in engineering lectin functionalized nanoparticles. Conjugating lectin with a nanosystem can identify and specifically attach to the carbohydrate moieties of glycoproteins expressed on cell surfaces and this has led to the development of several lectin functionalized nanoparticles to target drugs to various tissues with minimized systemic side effects. Such efficient lectin functionalized nanoparticles developed so far, and their role in targeted drug delivery, targeted therapies and oral immunization are reviewed. Technical difficulties behind designing and targeting these lectin functionalized nanoparticles are also discussed.
Keywords: Drug delivery, glycoprotein, immunization, nanocrystals, nanoparticles, photodynamic therapy.
Current Drug Delivery
Title:Lectins as Ligands for Directing Nanostructured Systems
Volume: 15 Issue: 4
Author(s): Ramaswamy Viswambari Devi*Michael Rajam Basil-Rose
Affiliation:
- Department of Advanced Zoology and Biotechnology, Holy Cross College, Nagercoil-629 004, Tamil Nadu,India
Keywords: Drug delivery, glycoprotein, immunization, nanocrystals, nanoparticles, photodynamic therapy.
Abstract: Lectins are proteins / glycoproteins of non-immunological origin found ubiquitously in all organisms. Research investigations show that many types of diseased tissues often display glycans that vary from their normal counterparts. Therefore, lectins that can interact with these transformed glycans may be used for early diagnosis and treatment of diseases. Specificity of lectins towards glycans has greatly attracted nanobiotechnology in engineering lectin functionalized nanoparticles. Conjugating lectin with a nanosystem can identify and specifically attach to the carbohydrate moieties of glycoproteins expressed on cell surfaces and this has led to the development of several lectin functionalized nanoparticles to target drugs to various tissues with minimized systemic side effects. Such efficient lectin functionalized nanoparticles developed so far, and their role in targeted drug delivery, targeted therapies and oral immunization are reviewed. Technical difficulties behind designing and targeting these lectin functionalized nanoparticles are also discussed.
Export Options
About this article
Cite this article as:
Devi Viswambari Ramaswamy *, Basil-Rose Rajam Michael , Lectins as Ligands for Directing Nanostructured Systems, Current Drug Delivery 2018; 15 (4) . https://dx.doi.org/10.2174/1567201815666180108101246
DOI https://dx.doi.org/10.2174/1567201815666180108101246 |
Print ISSN 1567-2018 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5704 |
Call for Papers in Thematic Issues
Advances of natural products, bio-actives and novel drug delivery system against emerging viral infections
Due to the increasing prevalence of viral infections and the ability of these human pathogens to develop resistance to current treatment strategies, there is a great need to find and develop new compounds to combat them. These molecules must have low toxicity, specific activity and high bioavailability. The most suitable ...read more
Electrospun Fibers as Drug Delivery Systems
In recent years, electrospun fibers have attracted considerable attention as potential platforms for drug delivery due to their distinctive properties and adaptability. These fibers feature a notable surface area-to-volume ratio and can be intentionally designed with high porosity, facilitating an increased capacity for drug loading and rendering them suitable for ...read more
Emerging Nanotherapeutics for Mitigation of Neurodegenerative Disorders
Conditions affecting the central nervous system (CNS) present a significant hurdle due to limited access of both treatments and diagnostic tools for the brain. The blood-brain barrier (BBB) acts as a barrier, restricting the passage of molecules from the bloodstream into the brain. The most formidable challenge facing scientists is ...read more
Nanotechnology Based Chemotherapy for the treatment of Head & Neck Cancer
The escalating recurrence rates observed in Head and Neck cancer, particularly within the chemo-therapeutically treated cohort (50-60%), can be attributed to the non-selective nature of current anticancer drug delivery modalities. In this context, nanotechnology-based drug delivery systems emerge as a promising avenue for achieving precise localization of therapeutic agents to ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Premature Ovarian Insufficiency and Long-Term Health Consequences
Current Vascular Pharmacology Mitochondrial Permeability Transition as Target of Anticancer Drugs
Current Pharmaceutical Design Dehydroepiandrosterone and Its Derivatives: Potentially Novel Anti-Proliferative and Chemopreventive Agents
Current Pharmaceutical Design Recent Developments of Steroid Sulfatase Inhibitors as Anti-Cancer Agents
Anti-Cancer Agents in Medicinal Chemistry Synthesis and In Vitro Biochemical Evaluation of a Series of Compounds as Potential Inhibitors of Estrone Sulfatase (ES) and the Role of pKa in both the Synthesis and the Inhibitory Activity of the Potential Inhibitors
Letters in Drug Design & Discovery Radionuclide Antibody-Conjugates, a Targeted Therapy Towards Cancer
Current Radiopharmaceuticals An Intelligent Artificial Bee Colony and Adaptive Bacterial Foraging Optimization Scheme for Reliable Breast Cancer Diagnosis
Recent Advances in Computer Science and Communications TGF-β2 Signaling in High-Grade Gliomas
Current Pharmaceutical Biotechnology Anti-adipogenic and Cytotoxic Effects of a New Compound from <i>Hartmannia rosea</i> G. Don
Current Pharmaceutical Analysis Plant Glycosides and Aglycones Displaying Antiproliferative and Antitumour Activities – A Review
Current Bioactive Compounds 1-Cyclohexylpiperazine and 3,3-Dimethylpiperidine Derivatives as Sigma-1 (σ1) and Sigma-2 (σ2) Receptor Ligands: A Review
Central Nervous System Agents in Medicinal Chemistry Editorial [ Hot Topic:Biology in Anticancer Treatment (Guest Editor: Bruno Vincenzi)]
Current Cancer Drug Targets Conjugation Approaches for Construction of Aptamer-Modified Nanoparticles for Application in Imaging
Current Topics in Medicinal Chemistry Pharmacokinetic Profiles of Anticancer Herbal Medicines in Humans and the Clinical Implications
Current Medicinal Chemistry An Aggressive Medical Approach for Inflammatory Bowel Disease: Clinical Challenges and Therapeutic Profiles in a Retrospective Hospitalbased Series
Current Clinical Pharmacology Editorial [Hot Topic Biomarkers, Molecular Imaging, and Novel Therapies of Cancer]
Current Molecular Medicine Genetic and Epigenetic Signatures in Human Hepatocellular Carcinoma:A Systematic Review
Current Genomics Impact of Immune Response on the Use of iPSCs in Disease Modeling
Current Stem Cell Research & Therapy Research Toward Potassium Channels on Tumor Progression
Current Topics in Medicinal Chemistry Molecule of the Month
Current Topics in Medicinal Chemistry